|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 417.5 TWD | -1.18% |
|
+10.45% | +118.30% |
Caliway Biopharmaceuticals Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was TWD 15.23 million compared to TWD 0.072 million a year ago. Net loss was TWD 261.14 million compared to TWD 118.2 million a year ago.
Basic loss per share from continuing operations was TWD 2.12 compared to TWD 1.055 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +118.30% | 182.36Cr | |
| +38.30% | 72TCr | |
| +34.28% | 59TCr | |
| -4.33% | 37TCr | |
| +20.19% | 33TCr | |
| +2.99% | 28TCr | |
| +17.02% | 24TCr | |
| +9.31% | 21TCr | |
| -5.07% | 21TCr | |
| -0.16% | 17TCr |
CALIWAY BIOPHARMACEUTICALS CO., LTD. 
